Main Session: New Drug Updates in Hematologic Malignancies: CAR T Cells, Targeted Therapeutics, and Other Agents

How are patients selected for CAR-T therapy?

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on hematologic cancers: drug updates.


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here